MedPath
FDA Approval

Choleystyramine Light

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 7, 2022
Labeling Type
Human Prescription Drug Label
Cholestyramine(4 g in 5.718 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Alkem Laboratories Limited

Ascend Laboratories, LLC

677605851

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Choleystyramine Light

Product Details

NDC Product Code
67877-422
Application Number
ANDA211799
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 20, 2021
ASPARTAMEInactive
Code: Z0H242BBR1Class: IACT
Code: 4B33BGI082Class: ACTIBQuantity: 4 g in 5.718 g
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3GClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
PROPYLENE GLYCOL ALGINATEInactive
Code: 26CD3J2R0CClass: IACT
FRUCTOSEInactive
Code: 6YSS42VSEVClass: IACT
PECTINInactive
Code: 89NA02M4RXClass: IACT
ORANGEInactive
Code: 5EVU04N5QUClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
© Copyright 2025. All Rights Reserved by MedPath